Abstract-We reported previously that maternal separation (MS) sensitizes adult rats to angiotensin II (Ang II)-induced hypertension. The aim of this study was to investigate the vascular reactivity to Ang II and the role of renin-angiotensin system components, reactive oxygen species production, and NO synthase (NOS) buffering capacity mediating the exacerbated Ang II-induced responses. MS rats were separated from their mothers for 3 h/d from days 2 to 14 of life. Controls were nonhandled littermates. At 12 weeks of age, aortic Ang II-induced constriction was greater from MS rats compared with controls (PϽ0.05); moreover, endothelial denudation abolished this difference. The response to other constrictors was unchanged. Angiotensin type 2 receptor function was reduced in aortic Ang II-induced constriction from MS rats compared with controls. Angiotensin type 1 receptor function was similarly abolished in both groups. However, protein expressions of angiotensin type 1 and angiotensin type 2 receptors were similar in aortic rings from MS and control rats. Preincubation with superoxide inhibitor or scavenger attenuated the Ang II-induced vasoconstriction in control but not in MS rats. However, acute preincubation with an NOS inhibitor enhanced aortic Ang II-induced constriction in aorta from control rats, but this effect was significantly reduced in MS rats compared with control rats. Accordingly, a further increase in Ang II-induced hypertension attributed to chronic NOS inhibition (days 10 to 13) was blunted in MS rats compared with control rats. Similar NOS expression and activity were observed in control and MS rats. 
W ithin the last decade, a growing body of evidence has linked adverse behavioral or environmental stress during early life with chronic diseases in adulthood. The quality of early life, prenatal and/or postnatal, can influence mechanism(s) of metabolic and mental disorders, as well as cardiovascular disease, in both humans [1] [2] [3] and animal models. 4 -6 Significant alteration in maternal care is considered a stressful experience associated with modifications in the endocrine response, 7, 8 leading to enhanced acute stressrelated responses in the offspring later in life. Maternal separation (MS) is a widely used model of early life behavioral stress in rodents (for review see Reference 9 ). Several studies reported that exposure to MS permanently alters the "programming" of the central nervous, endocrine, and immune systems. 10 -12 Recently, we reported that MS sensitizes adult rats to angiotensin II (Ang II)-induced hypertension and vascular inflammation. 13 These compelling experimental data led us to reason that early life stress, specifically MS, may induce defects in the renin-angiotensin system (RAS).
The RAS is composed of classic and nonclassic pathways. Classically, angiotensin-converting enzyme 1 metabolizes angiotensin I to Ang II, whereas angiotensin-converting enzyme 2 and neprilysin, components of the nonclassic pathway, metabolize various other angiotensin peptides. 14 Ang II type 1 (AT 1 ; AT 1a and AT 1b in the rat) receptor activation mediates vasoconstriction, vascular hypertrophy, and remodeling and promotes inflammatory cell activation, as well as sodium and water retention. 15, 16 It is well established that activation of NADPH oxidase and production of reactive oxygen species (ROS) are major AT 1 -mediated pathways in many cell types. 17 Ang II type 2 (AT 2 ) receptor activation is generally considered to be a counterregulatory receptor to AT 1 receptor activation. 18 Both AT 1 19, 20 and AT 2 21 receptors stimulate NO synthase (NOS) activity and NO production, which blunts the vasoconstrictor actions of the AT 1 receptor. 19 We hypothesized that MS induces a dysfunctional vascular phenotype, specifically an imbalance in AT 1 and AT 2 receptor activation that may exacerbate ROS production and/or reduce the NOS buffering capacity, ultimately leading to vascular dysfunction and promoting cardiovascular disease. ROS are linked to the mechanism underlying reduced NOS buffering capacity, given that superoxide can react with NO and diminish NO bioavailability. 22, 23 Thus, the aim of this study was to investigate Ang II-mediated vascular reactivity and the role of the endothelium, RAS components, ROS production, and NOS buffering capacity mediating the exacerbated Ang II-induced responses. Receptor mediated mechanism(s), as well as expression and localization of aortic RAS pathway components in MS and control rats, will also be determined. In addition, we designed studies to elucidate the role of NOS buffering capacity ex vivo and in vivo mediating Ang II-induced vasoconstrictor responses by using an NOS nonselective inhibitor, N G -nitro-L-arginine methyl ester (L-NAME).
Methods
Detailed methods are provided in the online Data Supplement (http://hyper.ahajournals.org).
Animal Model
All of the animal use protocols received previous approval by the institutional animal care and use committee at the Georgia Health Sciences University. Using Wistar-Kyoto rats, MS protocol was performed as described previously. 13 Briefly, approximately half of the male pups were separated from their mothers (MS) and littermates by transferring the pups to a clean cage in an incubator (30Ϯ1°C) for 3 hours from day 2 to day 14 of life. Normally reared nonhandled littermates served as the control group. Each experimental group of rats originated from a minimum of 3 different litters.
Aortic Vascular Reactivity
Thoracic aortic tissue was isolated as described previously. 24 Cumulative concentration-response curves were generated for Ang II, endothelin 1 (from 1ϫ10 Ϫ12 to 3ϫ10 Ϫ6 M), phenylephrine (from 1ϫ10 Ϫ9 to 3ϫ10 Ϫ5 M), and potassium chloride (from 4.7 to 100.0 mmol/L). The following compounds were used to preincubate (30 minutes) aortic rings before Ang II-induced constriction: candesartan (AT 1 receptor antagonist; 10 Ϫ5 M) and PD123,319 (AT 2 receptor antagonist; 10 Ϫ6 M), L-NAME (NOS inhibitor; 10
apocynin (NADPH oxidase inhibitor; 3ϫ10 Ϫ4 M), and cellpermeable superoxide dismutase (1000 U/mL).
Protein Expression
Whole tissue homogenates (NOS isoforms) and membrane preparations (AT receptors, see online Data Supplement for detailed protocol) were obtained from aortic tissue. Equal protein amounts were loaded and run in SDS-PAGE analysis followed by immunoblotting on polyvinylidene difluoride blots. Two-color immunoblots were analyzed using polyclonal primary antibodies to AT 1 , AT 2 , NOS1, NOS2, and NOS3 and detected by immunofluorescence. Densitometric results were reported normalized to ␤-actin.
NOS Enzymatic Activity
NOS enzymatic activity and expression were performed as described previously. 25 NOS activity was normalized to total protein concentration (Bradford method, BioRad) and expressed as picomoles of citrulline per milligram of protein per 30 minutes.
Immunohistochemical Analysis of Aortic Tissue
Rats were anesthetized with pentobarbital, and aortic rings were removed, rinsed in saline, and immersed in 10% buffered formalin overnight at room temperature and paraffin-embedded as described previously. 13 After staining, sections were viewed with an Olympus BX40 microscope (Olympus America, Melville, NY) on bright-field setting fitted with a digital camera (Olympus DP12, Olympus America).
Chronic Inhibition of NOS
L-NAME was administered in the drinking water from week 14 to 15 (10 mg/kg per day), week 16 (50 mg/kg per day), and week 17 of life (100 mg/kg per day). Mean arterial pressure was monitored by telemetry, as described previously. 13 Blood pressure was expressed as a 24-hour average at baseline, day 7, day 14, and day 28. A separate group of telemetry-implanted rats was infused with Ang II. On days 10 to 13 of Ang II infusion, rats were treated with L-NAME in drinking water (100 mg/kg per day).
Statistical Analysis
Linear and logarithmic data are presented as meanϮSE. Basal parameters in Table S1 (available in the online Data Supplement at http://hyper.ahajournals.org) were compared using unpaired Student t test. Vascular reactivity data were compared between concentrations by unpaired Student t test or 1-way ANOVA with Bonferroni post hoc performed using GraphPad Prism version 5.01 for Windows (GraphPad Software, San Diego, CA). A value of PϽ0.05 was considered statistically significant.
Results

Aortic Vasoconstriction
Maximal Ang II-induced vasoconstriction was significantly greater in aortic rings from MS than control rats ( Figure 1A and Table S1 ). No differences in EC 50 were observed between MS and control rats (Table S1 ). Absolute tension in response to Ang II (Table S2 ) was also significantly higher in aortic tissue of MS rats (44.5Ϯ2.4 mN) compared with control rats (34.3Ϯ1.8 mN; PϽ0.05). Denudation of the endothelium revealed that Ang II induced a similar response in aortic rings from MS and control rats ( Figure 1B ). Preincubation with an AT 1 receptor blocker (candesartan; 10 mol/L) abolished the Ang II-induced constriction in endothelium-intact aorta from both MS and control rats ( Figure 2A ). Selective AT 2 receptor blockade (PD123,319; 1 mol/L) significantly increased the Ang II-induced constriction in aortic rings from control rats ( Figure 2B ), whereas preincubation with the AT 2 receptor blocker did not display a functional change in vasoconstriction in aortic rings of MS rats. EC 50 in the presence and absence of receptor blockers was similar in MS and control rats (Table S1 ).
To elucidate whether the enhanced Ang II-mediated constriction is specific for Ang II, we analyzed the vasoconstrictor responses to phenylephrine, potassium chloride, and endothelin 1 in aortic rings from MS and control rats ( Figure  S1 ). No significant differences between groups were found in the percentage of maximum contraction or Ϫlog EC 50 (Tables S1 and S2 ).
Aortic AT 1 and AT 2 Receptor Expression and Immunolocalization
Protein expressions of AT 1 (43 kDa) and AT 2 (band at 50 kDa) receptors were similar in membrane preparations of aortic tissue of control and MS rats ( Figure 3A) . Immunolocalizations of AT 1 ( Figure 3B and 3C) and AT 2 ( Figure 3E and 3F) receptors are similar in the endothelium and smooth muscle from control and MS rats, respectively. Specificity of the AT 1 and AT 2 receptor immunoreactivity was verified with antigen blockade for immunohistological analysis (Figure 3D and 3G ). Aortic mRNA expression of RAS components was assessed by quantitative real-time PCR from MS and control rats ( Figure S2 ). AT 1 receptor, mas receptor, angiotensin-converting enzyme 1, angiotensin-converting enzyme 2, and neprilysin mRNA expression were similar between groups. AT 2 receptor mRNA expression was significantly reduced in aorta from MS rats compared with control rats (PϽ0.05).
Aortic Ang II-Mediated ROS and NOS Signaling During Vasoconstriction
Preincubation with apocynin (300 mol/L; NADPH oxidase inhibitor) or cell-permeable superoxide dismutase (1000 U/mL; superoxide scavenger) significantly blunted the Ang II-induced vasoconstriction in intact aortic rings from control rats ( Figure 4A and 4C) . Surprisingly, these compounds did not modify the Ang II-induced response in aortic rings from MS rats ( Figure 4B and 4D) .
Preincubation with the NOS inhibitor (L-NAME; 100 mol/L) elicited a significantly greater Ang II-induced constriction in intact aortic rings compared with untreated aortic rings from control rats ( Figure 5A ). L-NAME treatment also produced an increased Ang II-induced constriction in intact aorta from MS rats ( Figure 5B ), although the response was significantly less than the response in control rats ( Figure  5C ). Maximal vasoconstriction in the presence of L-NAME was increased in intact aortic tissue from MS rats compared with control rats ( Figure S3 ). The Ang II-induced constriction in the presence of L-NAME was similar in endotheliumdenuded aortas from control and MS rats ( Figure S4 ).
Blood Pressure During Chronic In Vivo NOS Inhibition
Mean arterial pressure at day 10 of Ang II infusion, before NOS blockade, was significantly greater in MS rats (142.0Ϯ0.9 mm Hg) compared with control rats (132.1Ϯ2.8 mm Hg; PϽ0.05; Figure  6A ), confirming our previously published results. 13 L-NAME treatment, during Ang II infusion, significantly increased mean arterial pressure within 24 hours in control rats, whereas MS rats displayed a blunted response ( Figure 6B ). The total pressor response in Ang II-infused rats treated with L-NAME for 3 days (days 10 to 13 during Ang II infusion) was significantly greater in control rats (158.3Ϯ2.5 mm Hg) compared with MS rats (146.4Ϯ2.9 mm Hg; PϽ0.005; Figure S5) . The heart rate increase in response to chronic NOS inhibition during Ang II infusion was severely attenuated in MS rats ( Figure S5 ). Chronic in vivo administration of L-NAME (in the absence of Ang II infusion) induced a dose-dependent increase in blood pressure in control and MS rats ( Figure S6) . Analysis of the slope revealed significantly attenuated effects of L-NAME on blood pressure in MS rats ( Figure S6 ; Pϭ0.028). Conversely, chronic L-NAME administration, in the absence of Ang II infusion, induced similar decreases in the heart rate in control and MS rats ( Figure S6 ).
Vasorelaxation, NOS Activity, and NOS Expression
Endothelium-dependent and -independent vasorelaxation in aortic rings from MS and control rats were determined by analyzing responses to acetylcholine and sodium nitroprusside. Responses were similar from both groups (Figure 7A  and 7B and Table S1 ). Total and isoform-specific NOS activity were determined in homogenates of aortic tissue from MS and control rats. No significant differences were observed in total or isoform-specific NOS activity ( Figure 7C ). Aortic NOS1 (155 kDa) and NOS3 (135 kDa) expression by Western blot were found to be similar in both groups of rats ( Figure 7D ). NOS2 expression was below detection (data not shown). In addition, NOS3 expression was determined by immunohistochemical analysis. NOS3 was highly expressed in the aortic endothelium in both MS and control rats ( Figure  S7 ). Additional staining in the absence of primary antibody served as a negative control and confirmed the absence of immunoreactivity ( Figure S7 ).
Discussion
This study revealed that MS, a model of early life stress, induces a dysfunction in endothelial Ang II receptor signaling and NOS buffering. Specifically, aortic tissue from MS rats demonstrated a significantly increased Ang II-induced constriction compared with control rats that results from a loss in endothelial-and Ang II-mediated NO production. In addition, aortic tissue from MS rats showed a loss of functional AT 2 receptor activation, which appears to account for the increased Ang II-induced constriction. Furthermore, the blood pressure response to chronic in vivo NOS inhibition was significantly attenuated in MS rats, indicating that early life stress induces a phenotype with reduced NOS buffering capacity.
MS is considered a chronic behavioral stress model replicating the adverse environment during childhood in humans. 26 Therefore, MS has been used to study behavioral consequences in stress-related responses; however, very few of these investigations have probed cardiovascular outcomes. Studies with animal models using glucocorticoid exposure 27, 28 or low protein diet 29 during the prenatal period demonstrate that these fetal programming paradigms affect the sensitivity of the RAS pathway directly. 29, 30 We reported recently that control and MS rats have similar circulating levels of Ang II, Ang (1-7), aldosterone, and plasma renin activity in baseline conditions, yet MS rats were found to be more sensitive to chronic Ang II-infused hypertension and vascular inflammation. 13 The current results, taken together with the previous findings, support our hypothesis that early life stress induces a vascular phenotype that predisposes the adult rat to endothelial dysfunction, a hallmark of cardiovascular disease. Furthermore, this study extends our knowledge of potential RAS-dependent mechanisms focused on the role of the vascular endothelium as a target affected by early life stress. Both AT 1 and AT 2 receptor activation include stimulation of the NO pathway; however, specific intracellular signaling pathways and subcellular localizations are yet to be clarified. Endothelial AT 1 receptor activates NO production via stimulation of protein kinase B (Akt) and phosphorylating NOS3. 31 Siragy et al 32 have reported that a chronic infusion of Ang II failed to increase NO release in AT 2 null mice. In addition, Tsutsumi et al 33 have shown that the overexpression of AT 2 receptors in the vasculature attenuates Ang II-induced hypertension. Alterations in the AT 1 :AT 2 ratio has been suggested as a possible mechanism leading to increased blood pressure. 34, 35 Our study did not observe any differences in immunolocalization of the AT 1 and AT 2 receptors within the vasculature nor any difference in protein expression of the receptors with a vascular membrane preparation; however, AT 2 mRNA expression was reduced in MS rats, as well as reduced AT 2 receptor function. Given that we did not observe differences in the wall thickness of control and MS aortas 13 and that the dysfunction is localized to the endothelium, we have reasoned that the increased Ang II reactivity may be intrinsic to angiotensin receptor signaling rather than expression. Further studies with isolated endothelial cells are necessary to elucidate the specific nature of the dysfunction in the Ang II signaling pathway.
The role of ROS mediating Ang II actions in the vasculature has been extensively reported to be via NADPH oxidase activation of superoxide. 36,37 Accordingly, we probed this pathway and observed that a cell-permeable superoxide scavenger and an NADPH oxidase inhibitor significantly reduced the aortic Ang II-induced constriction in control rats. To our surprise, neither cell-permeable superoxide dismutase nor apocynin modulated the aortic Ang II response in MS rats. Schuijt et al 38 reported that acute Ang II stimulation in human and porcine arteries is not mediated via superoxide generated through NADPH oxidase and/or xanthine oxidase activation but rather results in the generation of the vasodilator H 2 O 2 . At this point, it is unclear whether Ang II activates other ROS-dependent pathways, and further exper- A, Ang II-induced aortic constriction in control rats (nϭ12) was reduced after preincubation with apocynin (300 mol/L; nϭ7). B, Maternal separation (MS) rats showed similar Ang II-induced constriction in the presence (nϭ5) or absence (nϭ12) of apocynin. C, Ang II-induced aortic constriction in control rats (nϭ12) was reduced after preincubation with cell-permeable superoxide dismutase (PEG-SOD; 1000 U/mL; nϭ6). D, MS rats (nϭ12) showed similar Ang II-induced constriction using PEG-SOD. *PϽ0.05 vs untreated. iments are planned to determine the status of these pathways. We propose that MS induces a vascular phenotype that uncouples Ang II-mediated activation of NADPH oxidasemediated superoxide.
In vivo, NOS inhibition during chronic Ang II infusion and in the absence of Ang II infusion revealed a reduced sensitivity to increase blood pressure in MS rats compared with control rats. L-NAME induces a dramatic increase in blood pressure in control rats, especially during chronic Ang II infusion, but elicited a minimal change in MS rats. In addition, we observed that control rats displayed tachycardia as a consequence of NOS inhibition, whereas the heart rate was blunted in the MS rats in response to L-NAME. These data further support reduced NOS buffering capacity and (Ang II) infusion. Maternal separation (MS) rats (nϭ6) have exaggerated MAP to chronic Ang II infusion and a blunted pressor response to chronic L-NAME vs control rats (nϭ6). A, MAP expressed as 24-hour average. B, Change in the MAP in response to L-NAME treatment after 24 hours. *PϽ0.05 vs Ang II-infused control rats, #PϽ0.05 vs Ang II-infusedϩL-NAME control rats. A, Acetylcholine (ACh) and (B) sodium nitroprusside (SNP)-induced relaxation were similar in control (nϭ5) and maternal separation (MS; nϭ9) rats. C, Total NO synthase (NOS) and NOS isoform enzymatic activity were similar in MS (nϭ7) and control (nϭ7) rats. D, Representative Western blots for NOS1 and NOS3 from aortic tissue of MS and control rats (top) and densitometric analysis of NOS1 and NOS3 immunoreactivity revealed similar expression in aortic tissue between MS and control rats (bottom; nϭ4).
suggest differences in the NOS pathway in cardiac function in MS rats. Others have reported that rats treated chronically with L-NAME develop hypertension. 39, 40 Of note, most of the reports suggest that NOS inhibition in the central nervous system may increase the sympathetic activity and vagal suppression as well, 41 which could be responsible, at least in part, for the increase in arterial pressure occurring in the L-NAME hypertensive model. 40, 41 Thus, further investigation is necessary to determine the role that early life stress exerts on the brain, kidneys, and heart in the regulation of long-term blood pressure. Classically, endothelial dysfunction has been defined as blunted acetylcholine-induced vasorelaxation. Surprisingly, MS did not influence endothelium-dependent or -independent vasorelaxation pathways, NOS activity, NOS expression, or NOS immunolocalization. Interestingly, we compared Ang II-induced maximal constriction in the presence of L-NAME and found that the vasoconstriction is higher in MS than in control rats. Therefore, MS rats display an increased Ang II reactivity regardless of the status of NOS. These data suggest that early life stress mediates a dysfunctional vasoconstriction rather than vasorelaxation. Thus, the endothelial AT 1 and AT 2 intracellular signaling pathways require further investigation, specifically regarding the role of NOS. Taken together, our findings point to dysfunctional Ang II signaling to NOS during the contractile response as a mechanism by which early life stress induces permanent changes in the adult phenotype increasing the risk to develop cardiovascular disease. Future research will test the hypothesis that increased Ang II vasoconstriction in MS rats is mediated through reduced endothelial AT/NOS molecular signaling.
Perspectives
There is a consensus that adverse environment during early life programs biological consequences associated with stress and inflammatory response mechanisms in adulthood. 42 Indeed, this study distinguishes the impact of adverse early life environmental stressors on vascular function. New mechanistic strategies for the study of long-term consequences of early life stress in the development of cardiovascular disease are required. Figure S3 . Maximal vasoconstriction in response to AngII in presence of L-NAME in aortic tissue from control (n=7) and MS (n=6) rats. *p<0.05. Figure S4 . Endothelium-denuded aortic rings from A) control (n=7) and B) MS (n=6) rats in the presence and absence of L-NAME. A) B) Figure S5 . Cardiovascular response in AngII-infused rats treated chronically with L-NAME. A) Total pressor response (72 hr) in AngII-infused rats treated with L-NAME (day 10-13) is greater in control (n=6) than in MS (n=6) rats (#p<0.05). B) HR Changes in response to L-NAME administration in control and MS rats (n=6). * p<0.05. A) B) Figure S6 . Blood pressure and vascular reactivity in rats treated chronically with L-NAME. A) MAP in response to increasing doses of L-NAME in MS (n=3) and control rats (n=3). B) Chronic NOS inhibition decreased HR similarly in control and MS rats. * p<0.05. Figure S7 . Immunohistochemical analysis of aortic rings (n=6). NOS3 immunolocalizaiton in aorta from A) control rats and B) MS rats. C) Immunostaining in the absence of primary NOS3 antibody.
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